Keyword: treatment of inflammatory and autoimmune diseases
News
22.06.2023
-
Major drugmaker Eli Lilly is to pay up to $2.4 billion to acquire Dice Therapeutics, a US biotech specializing in developing oral medicines to treat chronic autoimmune...
News
13.02.2015
- Swiss fine and specialty chemicals producer Lonza has signed a toll manufacturing agreement with TiGenix, an advanced biopharmaceutical company focused on developing and...
